A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 506 participants.

Also called NCT01462877

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 506 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01462877
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01462877. Allocation not applicable; no masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2014-02 (actual). Results posted on 2015-02-23.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate Fenofibrate Combination With Statin in Chinese Patients With Dyslipidemic
Condition
Dyslipidemias
Condition
Cardiovascular Diseases
Condition
Hypertriglyceridemia
Intervention (Drug)
fenofibrate
Lead sponsor
Abbott (class: industry)
Collaborator
Rundo International Pharmaceutical Research & Development Co.,Ltd. (class: industry)

Record details

Record id
cardio:ct-nct01462877
Content hash
1fd022dda2f8092ea4d01951a5d937a94b123ab5e3431c94b98f6bbe0b03323d